October 13, 2011
OpGen, Inc. announced today the launch of Genome-Builder, a high performance software module that provides new, powerful capabilities for precision sequence assembly and significantly decreases the time and labor required for human, animal and plant genome sequence assembly. OpGen presented initial studies using Genome-Builder this week with its collaborators at the Sanger Institute during a [...]
October 13, 2011
Ann Arbor, MI - 3D Biomatrix, a leader in the development of three-dimensional (3D) cell culture products, and their collaborators have formed cellular spheroids from more than 20 cell lines utilizing Perfecta3D(TM) Hanging Drop Plates. The formation of spheroids from cell lines from several mammals (human, mouse, monkey) demonstrates that the versatility of the Hanging [...]
DNAnexus Secures $15 Million Funding Led by Google Ventures and TPG Biotech
October 12, 2011
MOUNTAIN VIEW, Calif. -- DNAnexus, a DNA data management and analysis platform, today announced that it has secured $15 million in second-round funding, led by Google Ventures and TPG Biotech. Additional participants in this round of financing include institutional investors First Round Capital, SoftTech VC, K9 Ventures, and Felicis Ventures. The new capital will help [...]
October 12, 2011
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) and the Agilent Technologies Foundation today announced that Steven Carr, Ph.D, who directs the Proteomics Platform at the Broad Institute of MIT and Harvard, has been selected for an Agilent Thought Leader Award supporting his work developing new technology for analyzing proteins and peptides. Carr’s goal is to produce [...]
Complete Genomics Launches Comprehensive Cancer Sequencing Service at ICHG/ASHG 2011
October 12, 2011
New service aimed at producing high-quality sequencing data from cancer genomes MOUNTAIN VIEW, Calif., and MONTRÉAL, Canada — Oct. 12, 2011 — Complete Genomics Inc. (NASDAQ: GNOM), the whole human genome sequencing company, introduced its new Cancer Sequencing Service today at the International Congress of Human Genetics (ICHG) and American Society of Human Genetics (ASHG) [...]
Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
October 12, 2011
CARLSBAD, Calif. -- Life Technologies Corporation today announced eight innovative new research products, including the Ion Sequencing 200 Kit, which enables 200 base pair reads. The Ion Personal Genome Machine™ sequencer is now the only next-generation sequencer that can deliver millions of highly accurate long reads in a single day. "Nine months after our launch, [...]
Roche Diagnostics Introduces Ultracompact LightCycler Nano Real-Time PCR System in US
October 12, 2011
INDIANAPOLIS and MONTREAL -- Roche announced today the U.S. launch of the latest addition to the company's real-time PCR portfolio of LightCycler® instruments for use in research, the LightCycler Nano real-time PCR system. Roche Applied Science made the announcement in conjunction with the start of the 61st annual meeting of the American Society of Human [...]
Lucigen Corporation Awarded $350k in SBIR Grants.
October 12, 2011
Lucigen Corporation is pleased to announce that it has recently been awarded two separate SBIR Phase I grants to fund additional research and development. The National Institutes of Health has awarded Lucigen a total of $350,000 in Small Business Innovation Research grants to be used to develop research tools with the potential to improve human [...]
Spectro Incorporated Introduces the SpectroVisc Q3000 Portable Kinematic Viscometer
October 12, 2011
Beijing – Spectro Inc. today announced the introduction of SpectroVisc Q3000, the world's first truly portable, solvent-free, temperature-controlled kinematic viscometer at the BCEIA instrumentation exhibition in Beijing. SpectroVisc Q3000 uses a patented split cell capillary (SCC) technique which allows the user to measure kinematic viscosity from only a few drops of oil, and no solvents [...]
October 12, 2011
Munich, Germany - Definiens®, the leading Health Image Intelligence™ company, today announced the release of its new Quantitative Digital Pathology portfolio, designed to advance translational research in pathology, specifically in biomarker development. The new portfolio will offer updated versions of Definiens Tissue Studio®, Definiens Developer XD™ as well as the introduction of a novel component, [...]

